My Gene Counsel

What My Gene Counsel does

My Gene Counsel is a digital health company founded in 2014 and headquartered in New Haven, Connecticut. It operates a B2B software and content platform that delivers clinically vetted, personalized genetic information to patients and providers through its proprietary Living Lab Reports® product, addressing the gap between genetic testing output and patient understanding. The platform is deployed across health systems, hospitals, cancer centers, biotech/pharma organizations, and rare disease foundations, and is led by certified genetic counselors Ellen Matloff (CEO) and Danielle Bonadies (Director of Genetics), with David Henderson as CFO/COO.

The company's core product, Living Lab Reports®, is a digital genetic counseling platform that delivers condition-specific content covering 90+ genes and hereditary conditions. The platform operates as an embedded solution within health system workflows, providing patients with ongoing access to updated, clinically relevant genetic information as guidelines evolve and their personal health context changes. Revenue is generated through B2B subscription and licensing arrangements with enterprise healthcare customers, who deploy Living Lab Reports® within their patient engagement infrastructure.

My Gene Counsel is a private LLC that has been largely bootstrapped, having raised only $500,000 in outside capital in 2016 from undisclosed investors. With a team of 1-10 employees, the company has maintained a lean operation while building a portfolio of enterprise customers and partnerships, including Ambry Genetics (2019), the Foundation for Prader-Willi Research (2021), the University of Alabama at Birmingham (2021), Tampa General Hospital (2023), Jupiter Medical Center (2024), FamGenix (2025), and N-Power Medicine (2026). The company was a Women of Innovation finalist in 2017 and an UberPITCH semifinalist in 2016.

Name

My Gene Counsel

Legal name

My Gene Counsel, LLC

Website

https://mygenecounsel.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

My Gene Counsel is a New Haven-based digital health company that provides Living Lab Reports®, a B2B subscription platform delivering clinically vetted genetic counseling content to health systems, hospitals, cancer centers, biotech/pharma firms, and rare disease foundations.

Ownership category

akta.pro rank

Product category

Digital Genetic Counseling Software

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK)

Keywords

• Digital genetic counseling
• Genetic testing platform
• Precision medicine software
• Clinical genomic tools
• Hereditary cancer screening

Headquarters

HQ city

North Haven

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Health Systems & Provider Licensing: My Gene Counsel licenses its digital genetic counseling platform and Living Lab Reports® to hospitals, health systems, and cancer centers. Healthcare systems pay for access to the platform to support their genetics programs, scale genetic counseling capacity, and improve patient engagement.
2. Laboratory & Biotech Partnerships: The company partners with genetic testing laboratories and biotech companies to provide patient-facing genetic counseling tools, digital result delivery, and long-term update services tied to specific genetic test results.
3. Precision Medicine Partners: Pharmaceutical and research partners utilize My Gene Counsel's tools to enhance clinical trial design, patient engagement, data interpretation, and reporting for genomic medicine programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

My Gene Counsel sells an AI-enabled digital genetic counseling platform that pairs specific genetic test results with continuously updated, evidence-based Living Lab Reports® for patients and clinicians. Offerings span family history intake and risk assessment, long-term automated notifications when guidelines change or variants are reclassified, and the One-Stop Solution bridging direct-to-consumer and medical-grade genetic testing. The platform is licensed to health systems, hospitals, cancer centers, genetic testing laboratories, biotech firms, and pharmaceutical / precision medicine partners.

Product overview

My Gene Counsel is a digital health company offering a suite of connected digital solutions for genetic counseling and precision medicine. The product portfolio centers on Living Lab Reports® as the core automated genetic report product, supplemented by Family History & Assessment for pre-appointment risk evaluation, and Long-Term Notifications for ongoing patient engagement when guidelines change. The company also offers a Digital Genetic Counseling Platform providing end-to-end genetic testing workflows including family history intake, guideline-concordant risk assessment, patient education, and result management. The One-Stop Solution sub-product bridges direct-to-consumer and medical-grade testing. Together, these products address the genomic care pathway from identifying at-risk patients through delivering continuously updated insights and maintaining long-term engagement.

Differentiator

Problem solved

Functional benefit

Brands

• Living Lab Reports®: Digital genetic counseling reports that provide continuously updated, evidence-based information linked to specific genetic test results for patients and healthcare providers

Products and services

• Living Lab Reports® Automated, web-based, continuously updated genetic reports that deliver evidence-based information linked to a patient's specific genetic test results, kept current as guidelines, risk assessments, and medical management recommendations evolve. Sold to health systems and providers to support long-term patient education and engagement.
• Family History & Assessment Digital family history intake and risk assessment tool that conducts pre-appointment surveys to identify at-risk patients and streamlines clinical workflows for determining genetic testing eligibility. Used by health systems, laboratories, and partners to scale hereditary risk assessment.
• Long-Term Notifications Automated notification service that sends patients and clinicians updates via text and email when genetic guidelines change, variants are reclassified, new health risk information is published, or relevant clinical trial opportunities arise, enabling long-term re-engagement.
• Digital Genetic Counseling Platform AI-enabled end-to-end platform combining family history intake, guideline-concordant risk assessment, patient education, and ongoing genetic result management. Licensed to health systems, laboratories, and precision medicine partners as the integrated workflow layer.
• One-Stop Solution Integrated solution that enables direct-to-consumer genetic test users to confirm hereditary cancer results through medical-grade testing with Ambry Genetics, bridging consumer and clinical-grade testing pathways.

Quantifiable outcome

• Hundreds of updates affecting 90+ hereditary cancer genes delivered to patients and clinicians in 2023-2024

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core, key and secondary.

• N-Power MedicinecoreStrategic or Co-development Partner · 9 April 2026My Gene Counsel and N-Power Medicine launched a precision medicine pilot at Pacific Cancer Care in Monterey, CA. My Gene Counsel's digital genetic counseling platform works alongside N-Power Medicine's prospective point-of-care platform to help oncology practices identify patients meeting national genetic testing guidelines. The collaboration aims to expand access to guideline-recommended hereditary cancer risk assessment and testing, with plans to replicate the model across N-Power's network of community oncology practices nationwide.
• FamGenixcoreStrategic or Co-development Partner · 18 March 2025Strategic partnership to provide healthcare centers with a comprehensive digital genetic risk assessment and education toolkit. The combined platform facilitates risk assessment for hereditary cancer, cardiovascular disease, kidney disease, lymphoma, reproductive disorders, rare diseases, biomarkers, and other genetic conditions. Includes pre- and post-test genetic education and ongoing genetic insights updates.
• Jupiter Medical CenterkeyStrategic or Co-development Partner · 25 January 2024Partnership to offer genetic services to all cancer patients at Jupiter Medical Center in Florida, supporting the cancer genetic counseling and testing program through My Gene Counsel's digital platform.
• Tampa General HospitalkeyStrategic or Co-development Partner · 29 November 2023Tampa General Hospital selected as site partner to utilize My Gene Counsel's digital genetic counseling tools that update to scale genetic testing for patients with breast, ovary, prostate, and pancreas cancer.
• Foundation for Prader-Willi ResearchkeyStrategic or Co-development Partner · 24 June 2021Selected to enable responsible return of results for the Prader-Willi syndrome Genome Project. My Gene Counsel provides updating digital genetic counseling reports to help research participants understand their genetic test results.
• O'Neal Comprehensive Cancer Center at UABkeyStrategic or Co-development Partner · 30 March 2021Partnership to boost genetic testing and improve precision cancer care. The digital solution enables physician-initiated testing, greater clinical support, and better use of genetic counseling resources at the cancer center.
• Ambry GeneticssecondaryTechnology or Integration · 18 March 2019Partnership to bridge the gap between direct-to-consumer genetic testing and medical-grade genetic testing. The One-Stop Solution allows direct-to-consumer kit users to confirm their hereditary cancer results with clinical-grade testing.

Scale indicators2 records

Recent moves8 records

Expansion highlights5 records

Emerging players

• Fabric Genomics: AI-driven clinical genomics interpretation platform used by clinical labs and health systems to turn sequencing data into clinically actionable reports; overlaps the upstream interpretation layer that pairs with My Gene Counsel's downstream patient-facing reporting.
• Genome360 (by 4medica) / GenomeSmart: Provider-facing genetic test recommendation and patient education workflow tools; an emerging competitor in the same healthcare-provider digital genetic counseling workflow niche that My Gene Counsel serves.

Broad incumbents

• Natera: Genetic testing company spanning oncology, reproductive health, and organ health with digital result delivery and patient engagement; overlaps My Gene Counsel's oncology and precision medicine use cases via integrated counseling and result reporting.
• Invitae: Large genetic testing lab with a broad hereditary cancer and rare disease menu and post-test digital tools including patient and clinician portals; an upstream potential buyer or partner and a competitor for health system oncology genetics spend.
• Color Health: Population-scale genetic testing and counseling platform offering hereditary cancer and other genetic tests with integrated clinician and patient tools; broader testing-services portfolio competes with My Gene Counsel's risk-assessment and reporting layer, especially in employer and health system channels.
• SOPHiA Genetics: Genomic data analysis and clinical interpretation platform deployed in hospitals globally; targets similar precision medicine and hereditary cancer reporting workflows and is a potential international peer if My Gene Counsel expands outside the US.
• GeneDx (Sema4): Clinical genetic testing laboratory offering hereditary cancer panels with provider reporting and patient-friendly result tools; competes with My Gene Counsel for the same oncology precision medicine budgets where labs bundle risk communication and digital tools into their services.
• Ambry Genetics: Clinical genetic testing lab and existing My Gene Counsel partner (Ambry One-Stop Solution); competes for hereditary cancer testing and integrated counseling workflows, but also routes demand for Living Lab Reports through the partnership.
• Tempus: AI-enabled precision medicine platform combining molecular profiling, clinical data, and provider-facing analytics with companion patient-facing tools in oncology; competes with My Gene Counsel for precision medicine program budgets at academic and community cancer centers.

Direct peers

• Genome Medical: Direct telehealth genetic counseling and genomics platform serving patients and providers with virtual genetic counselors and provider-to-provider consultations; competes head-on with My Gene Counsel's digital genetic counseling workflow for the same health system and patient populations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/MyGeneCounsel
• Facebookfacebook.com/MyGeneCounsel
• LinkedInlinkedin.com/company/my-gene-counsel-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about My Gene Counsel